本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Revolution Medicines, Inc.

52.95
-0.5400-1.01%
成交量:109.51萬
成交額:5,829.20萬
市值:98.98億
市盈率:-11.70
高:54.49
開:53.50
低:52.62
收:53.49
52周最高:62.40
52周最低:29.17
股本:1.87億
流通股本:1.59億
量比:0.53
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-4.5252
每股收益(LYR):-3.5776
淨資產收益率:-46.61%
總資產收益率:-26.47%
市淨率:5.31
市盈率(LYR):-14.80

資料載入中...

2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/23

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/01

重要事件披露

Form 8-K - Current report